SCHEMBL22011594

SCHEMBL22011594

c1ccc(-c2ccc3c(c2)[nH]c2c4ccc5oc6ccccc6c5c4c4c5ccccc5oc4c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ CDK4 P11802 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ PLA2G2A P14555 2/20 0.38
▸ PLA2G4A P47712 2/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.37
▸ MAP3K11 Q16584 2/20 0.37
▸ MAP3K9 P80192 1/20 0.37
▸ CSF1R P07333 1/20 0.36
▸ PDGFRB P09619 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011721 0.86 MAP3K11 (0.47) MEN1MAPTKMT2ACDK4CCND1
SCHEMBL15127073 0.86 KDM4E (0.48) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL22708929 0.82 MAP3K11 (0.44) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL17451755 0.81 GABRP (0.44) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL19784586 0.81 MAPT (0.38) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL25703026 0.79 PLA2G2A (0.46) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL15126728 0.78 MEN1 (0.44) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL17451766 0.77 CDK5 (0.46) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL16310389 0.77 CDK4 (0.42) MEN1MAPTKMT2AKDM4EGAA
SCHEMBL25689151 0.76 CDK4 (0.51) MEN1MAPTKMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 — — EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 — — US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 MEN1 1681/4885MAPT 4261/4885KMT2A 1372/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 MEN1 1681/4885MAPT 4261/4885KMT2A 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback